Replies to post #15709 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

MNTA's 0-for-2 record on novel drugs is not great; OTOH, MNTA is 2-for-2 on reverse engineering complex drugs from other companies, both of which were accomplishments that many analysts and investors said could not be done.